CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Fleury SA Company Snapshot
Fleury SA operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fleury SA with three other pharmaceutical manufacturers in Latin America: Genomma Lab Internacional Sab De Cv of Mexico (2018 sales of 11.79 billion Mexican Pesos [US$613.07 million] of which 103% was PC), Diagnosticos Da America SA (3.93 billion Brazilian Reals [US$940.80 million] of which 100% was servi os auxiliares), and Hypera SA (3.72 billion Brazilian Reals [US$890.78 million] ).

Sales Analysis. During the year ended December of 2018, sales at Fleury SA were 2.66 billion Brazilian Reals (US$637.29 million). This is an increase of 11.8% versus 2017, when the company's sales were 2.38 billion Brazilian Reals. This was the fifth consecutive year of sales increases at Fleury SA (and since 2013, sales have increased a total of 61%). Sales of Diagnostic Medicine saw an increase of 12.0% in 2018, from 1.99 billion Brazilian Reals to 2.23 billion Brazilian Reals.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Fleury SA
  Stock Performance Chart for Fleury SA
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 24.60
(Figures in Brazilian Reals)
1 Week -1.6%   13 Weeks 1.2%  
4 Weeks 3.6%   52 Weeks 13.9%  
 
Fleury SA Key Data:
  Ticker: FLRY3 Country: Brazil
  Exchanges: SOP Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2018 Sales 2,664,463,000
(Year Ending Jan 2019).
Employees: 9,400
  Currency: Brazilian Reals Market Cap: 7,776,390,673
  Fiscal Yr Ends: December Shares Outstanding: 316,113,442
  Share Type: Ordinary Closely Held Shares: 110,756,564
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.